在药物发现中探索USFDA批准的基于伊米达的小分子:一个迷你视角
Sonali Gupta1,2, M Arockia Babu3, Roshan Kumar4,5
1Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, Gurukul Kangri (Deemed to be University), Haridwar, India.
Chemistry & biodiversity
|March 10, 2025
概括
伊米达环在药物发现中至关重要,最近批准了抗感染药物和其他条件. 关键发现包括批准的基于伊米达的药物的共同代谢途径和化学结构.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 伊米达环是药物化学中的重要支架,经常被纳入药物分子中.
- 最近批准的药物突出显示了伊米达衍生物在治疗应用中的持续重要性.
研究的目的:
- 分析2013年至2024年期间的关键药物批准,其中包括伊米达环.
- 研究这些批准药物的药理学,代谢,化学和合成特性.
- 探索伊米达作为生物的作用及其受体-连接体相互作用.
主要方法:
- 对药物批准数据 (2013-2024) 的审查,重点关注含有伊米达的药物.
- 药理分析,包括治疗领域和剂量形式.
- 分析代谢途径 (CYP3A4,CYP3A5),分泌途径 (便) 和化学结构 (异环,替代,性).
- 检查合成路径,生物异构体效用和受体-连接体相互作用.
主要成果:
- 在20种批准的药物中,45%是抗感染药物,其他药物针对遗传,代谢,内分泌,瘤,心血管,胃肠道和神经系统疾病.
- 主要是固体剂型和口服.
- CYP3A4和CYP3A5是关键的代谢酶,便分泌是主要的途径.
- 罗利丁/醇和醇是常见的异环; 胺基,氨基和基组是频繁的替代; 观察到2,4-替代模式和性.
结论:
- 伊米达环在现代药物发现中仍然是一个多功能和重要的支架,特别是在抗感染药物中.
- 了解基于伊米达的药物的代谢,化学和相互作用概况,有助于设计未来的治疗方法.
- 本综述为药物化学家和研究人员在优化含有伊米达的候选药物方面提供了宝贵的见解.
相关概念视频
01:26Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K